I-Mab Files 6-K with Investor Presentation and Press Release

Ticker: NBP · Form: 6-K · Filed: Jun 6, 2024 · CIK: 1778016

Sentiment: neutral

Topics: disclosure, investor-relations, filing

TL;DR

I-Mab dropped new investor decks and press releases on June 5-6, 2024. Check for updates.

AI Summary

I-Mab, a biopharmaceutical company, filed a Form 6-K on June 6, 2024, to report an investor presentation dated June 5, 2024, and a press release dated June 6, 2024. The filing includes information about the company's business and its principal executive office located at 2440 Research Blvd, Suite 400, Rockville, MD 20850.

Why It Matters

This filing provides investors with updated information and communications from I-Mab, potentially impacting their investment decisions regarding the company's biopharmaceutical developments.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate communications and does not contain new financial results or significant operational changes.

Key Players & Entities

FAQ

What type of documents were filed by I-Mab on June 6, 2024?

I-Mab filed a Form 6-K on June 6, 2024, which included an investor presentation dated June 5, 2024, and a press release dated June 6, 2024.

What is the principal executive office address for I-Mab?

The principal executive office of I-Mab is located at 2440 Research Blvd, Suite 400, Rockville, MD 20850.

Who signed the Form 6-K on behalf of I-Mab?

The Form 6-K was signed by Joseph Skelton, Chief Financial Officer, on behalf of I-Mab.

What is the SEC file number for I-Mab?

The SEC file number for I-Mab is 001-39173.

What is the SIC code for I-Mab?

The Standard Industrial Classification (SIC) code for I-Mab is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 154 words · 1 min read · ~1 pages · Grade level 11.3 · Accepted 2024-06-06 07:14:34

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June, 2024 Commission File Number: 001-39173 I-MAB (Translation of registrant’s name into English) 2440 Research Blvd, Suite 400 Rockville, MD 20850 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Investor Presentation of I-Mab, dated June 5, 2024 99.2 Press Release of I-Mab, dated June 6, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 6, 2024 I-MAB By: /s/ Joseph Skelton Name: Joseph Skelton Title: Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing